↓ Skip to main content

Mild disease course of SARS-CoV-2 infections and mild side effects of vaccination in Pompe disease: a cohort description

Overview of attention for article published in Orphanet Journal of Rare Diseases, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
38 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mild disease course of SARS-CoV-2 infections and mild side effects of vaccination in Pompe disease: a cohort description
Published in
Orphanet Journal of Rare Diseases, March 2022
DOI 10.1186/s13023-022-02268-y
Pubmed ID
Authors

G. Ismailova, M. J. Mackenbach, J. M. P. van den Hout, A. T. van der Ploeg, E. Brusse, M. A. E. M. Wagenmakers

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 16%
Researcher 5 13%
Student > Bachelor 4 11%
Professor 2 5%
Student > Ph. D. Student 1 3%
Other 3 8%
Unknown 17 45%
Readers by discipline Count As %
Nursing and Health Professions 7 18%
Medicine and Dentistry 6 16%
Linguistics 1 3%
Business, Management and Accounting 1 3%
Social Sciences 1 3%
Other 1 3%
Unknown 21 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2022.
All research outputs
#4,637,036
of 23,275,636 outputs
Outputs from Orphanet Journal of Rare Diseases
#631
of 2,669 outputs
Outputs of similar age
#105,827
of 440,209 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#21
of 141 outputs
Altmetric has tracked 23,275,636 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,669 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,209 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 141 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.